Edgewise Therapeutics presented long-term clinical results for sevasemten, its investigational oral treatment for Becker and Duchenne muscular dystrophies, at the 30th Annual Congress of the World ...
Long-term treatment with givinostat in boys with Duchenne muscular dystrophy continues to show a favourable safety and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback